The Online Investor
OLI Premium
Contrarian Outlook
Stock Option Ideas
Preferred Stock Newsletter
ChartZero.com
ChartZero
Global Blood Therapeutics Inc (GBT)

Global Blood Therapeutics is a clinical-stage biopharmaceutical company determined to discover, develop and deliver treatments that provide hope to underserved patient communities. Co.'s primary product candidate is voxelotor, an oral, once-daily therapy that modulates hemoglobin's affinity for oxygen, which inhibits hemoglobin polymerization in sickle cell disease (SCD). Co. is evaluating voxelotor in adult and adolescent patients with SCD in a Phase 3 clinical trial. Co. is also evaluating the safety and pharmacokinetics of single and multiple doses of voxelotor in adolescent and pediatric patients with SCD in a Phase 2a clinical trial.

GBT SEC Filing Email Alerts Service

Company Name:  Global Blood Therapeutics Inc
Website:  www.globalbloodtx.com
Sector:  Drugs & Pharmaceuticals
Number of ETFs Holding GBT:  27
Total Market Value Held by ETFs:  $418.63M
Total Market Capitalization:  $2.98B
% of Market Cap. Held by ETFs:  14.07%
October 21, 2019    11:25 PM Eastern


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Quotes delayed 20 minutes



Strong Buy (3.85 out of 4)
75th percentile
(ranked higher than approx. 75% of all stocks covered)
Based on Zacks ABR data;
powered by Xignite

Global Blood Therapeutics Inc (GBT) Page | The Online Investor | www.TheOnlineInvestor.com | Copyright © 1998 - 2019, All Rights Reserved

Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes, powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.